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Abstract
Background: The severity of canine leishmaniosis (CanL) due to Leishmania infantum might be affected by other
vector-borne organisms that mimic its clinical signs and clinicopathological abnormalities. The aim of this study was
to determine co-infections with other vector-borne pathogens based on serological and molecular techniques in
dogs with clinical leishmaniosis living in Spain and to associate them with clinical signs and clinicopathological
abnormalities as well as disease severity.
Methods: Sixty-one dogs with clinical leishmaniosis and 16 apparently healthy dogs were tested for Rickettsia
conorii, Ehrlichia canis, Anaplasma phagocytophilum and Bartonella henselae antigens by the immunofluorescence
antibody test (IFAT) and for E. canis, Anaplasma spp., Hepatozoon spp., Babesia spp. and filarioid DNA by polymerase
chain reaction (PCR).
Results: Among the dogs examined by IFAT, the seroprevalences were: 69% for R. conorii, 57% for E. canis, 44% for
A. phagocytophilum and 37% for B. henselae; while the prevalences found by PCR were: 8% for Ehrlichia/Anaplasma,
3% for Anaplasma platys and 1% for H. canis. No other pathogen DNA was detected. Statistical association was
found between dogs with clinical leishmaniosis and seroreactivity to R. conorii antigen (Fisher’s exact test: P = 0.025,
OR = 4.1, 95% CI = 1–17) and A. phagocytophilum antigen (Fisher’s exact test: P = 0.002, OR = 14.3, 95% CI = 2–626)
and being positive to more than one serological or molecular tests (co-infections) (Mann-Whitney test: U = 243, Z = -2.6,
n1 = 14, n2 = 61, P = 0.01) when compared with healthy dogs. Interestingly, a statistical association was found between
the presence of R. conorii, E. canis, A. phagocytophilum and B. henselae antibodies in sick dogs and some
clinicopathological abnormalities such as albumin and albumin/globulin ratio decrease and increase in serum
globulins. Furthermore, seroreactivity with A. phagocytophilum antigens was statistically associated with CanL clinical
stages III and IV.
Conclusions: This study demonstrates that dogs with clinical leishmaniosis from Catalonia (Spain) have a higher rate of
co-infections with other vector-borne pathogens when compared with healthy controls. Furthermore, positivity to
some vector-borne pathogens was associated with more marked clinicopathological abnormalities as well as disease
severity with CanL.
Keywords: Canine leishmaniosis, Spain, Leishmania infantum, Rickettsia conorii, Ehrlichia canis, Anaplasma
phagocytophilum, Anaplasma platys, Hepatozoon canis, Bartonella henselae, Co-infection
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Background
Canine leishmaniosis (CanL) is a zoonotic protozoan
disease caused by Leishmania infantum endemic in the
Mediterranean basin. Phlebotomus spp. sand flies are the
only vector adapted for the biological transmission of L.
infantum in Europe [1]. Dogs (Canis familiaris) are con-
sidered the main peridomestic reservoir of this parasite
in endemic areas [2]. Prevalence of canine L. infantum
infection can be as high as 67% in selected populations
[3], but the prevalence of clinical disease is usually lower
than 10% [4]. The most useful diagnostic methods of
CanL include quantitative serological techniques and
PCR, although the direct observation of amastigote
forms of Leishmania spp. is also helpful in the clinical
setting [4–6].
The clinical manifestations of CanL can vary from ab-
sence of clinical signs and clinicopathological abnormal-
ities to a severe fatal clinical illness. The most common
clinical signs are skin lesions, generalized lymphadenome-
galy, progressive weight loss, decreased appetite, lethargy,
muscular atrophy, exercise intolerance, splenomegaly,
polyuria and polydipsia, ocular lesions, epistaxis, lameness,
vomiting and diarrhea [2, 4, 6].
In the Mediterranean basin, other canine vector-
borne diseases are common. Some studies have docu-
mented Ehrlichia canis [7–12], Anaplasma platys
[10, 12] and Rickettsia conorii [8, 9, 13, 14] infections
in dogs. These intracellular Gram-negative bacteria
are transmitted or likely transmitted by Rhipicephalus
sanguineus (sensu lato) ticks [14–19]. It has been re-
ported that the prevalence of these vector-borne in-
fections is higher in communal shelter dogs and dogs
that live outdoors [9, 12]. The clinical characteristics
of rickettsial disease in dogs can be similar to those
caused by L. infantum. Anaplasma phagocytophilum
[8, 9, 11, 12] is another canine pathogen transmitted
by Ixodes ricinus ticks that can infect dogs and
humans causing acute febrile illness or transient sub-
clinical infection [12, 20]. Other protozoan pathogens
such as Babesia vogeli [10] and Hepatozoon canis [10] in-
fect dogs in the Mediterranean basin and are also trans-
mitted by R. sanguineus (s.l.) ticks [15, 17, 18].
Bartonella spp. are vector-borne bacteria that cause
diseases in humans and animals globally, including Eur-
ope [7, 8]. Numerous species of Bartonella have been
identified as pathogenic to humans while Bartonella vin-
sonii berkhoffii and Bartonella henselae are associated
with clinical disease in dogs [21]. Dirofilariasis due to
Dirofilaria immitis or Dirofilaria repens is another
vector-borne disease transmitted by mosquitoes from
the family Culicidae present in Europe [8, 12, 22, 23]
that can affect both animals and humans [24], causing
cardiopulmonary or subcutaneous disease manifesta-
tions, respectively [24].
It has been reported that infections with other vector-
borne organisms can affect the severity of CanL or
mimic its clinical signs and/or clinicopathological abnor-
malities [25–27]. Some studies have described co-
infection of L. infantum with other vector-borne diseases
in dogs with typical signs of leishmaniosis [7, 10, 28, 29].
Other authors have demonstrated co-infections with L.
infantum and E. canis, A. phagocytophilum and Barto-
nella spp. in the Mediterranean area [11, 26, 30, 31].
Mekuzas et al. [30] found that clinical signs were more
frequent in dogs with dual L. infantum and E. canis in-
fection than dogs with a single infection. Roura et al. [7]
found that simultaneous infection with two or more
pathogens should be expected in dogs living in areas
which are highly endemic for several vector-borne path-
ogens, mainly in dogs kept predominantly outdoors and
not regularly treated with ectoparacitides.
The aim of this study was to determine co-infections
with other vector-borne pathogens in dogs with clinical
leishmaniosis living in Catalonia (Spain) and to associate
with clinical signs and clinicopathological abnormalities
as well as with disease severity. These dogs were com-
pared with healthy control dogs living in the same geo-
graphical area.
Methods
Dogs
The dogs included in this study were from Catalonia
(Spain), an area endemic for CanL and other vector-
borne diseases. Sixty-one sick dogs were diagnosed with
clinical leishmaniosis based on compatible clinicopatho-
logical findings and a medium or high antibody level in
a quantitative ELISA for the detection of L. infantum-
specific antibodies and cytology or histology in some
cases. Physical examination; a complete blood count
(CBC) with blood smear examination (System Siemens
Advia 120; Siemens Healthcare GmbH, Erlanger,
Germany); a biochemical profile including creatinine,
urea, total proteins, alanine transaminase (ALT) and
total cholesterol (Analyzer Olympus AU 400; Beckman
Coulter Inc., Brea, CA, USA); urinalysis with urinary
protein creatinine ratio; and serum electrophoresis were
performed. Reference intervals for the hematological and
biochemical parameters were employed as previously de-
scribed [32]. The dogs were examined at different veter-
inary centers: 33 were from Fundació Hospital Clínic
Veterinari (Bellaterra, Barcelona, Spain), 15 were from
Hospital Ars Veterinaria (Barcelona, Barcelona, Spain), 7
from Hospital Mediterrani Veterinaris (Reus, Tarragona,
Spain) and 6 from Consultori Montsant (Falset, Tarragona,
Spain). The following clinical signs were recorded: fever,
weight loss, skin lesions, ocular lesions, lymphadenome-
galy, muscular atrophy, splenomegaly, vomiting and diar-
rhea, joint pain, polyuria and polydipsia, lameness,
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epistaxis and neurological disorders. Lymphadenomegaly
was classified as mild, moderate or marked depending on
the relative size of the enlarged lymph node. Furthermore,
the dogs were classified according to the LeishVet clinical
staging system [4]. Leishmania real-time PCR (qPCR) was
performed on blood from all dogs [33].
Sixteen apparently healthy dogs from Barcelona prov-
ince, based on clinical history, normal physical examin-
ation, seronegative and qPCR-negative for Leishmania
were also studied for comparison with the sick dogs.
Healthy dogs were from Barcelona province and were
also examined at the same veterinary centres.
Samples
Six millilitres of blood were collected from the dogs by
jugular or metatarsal venipuncture for the laboratory
tests described above. Blood was transferred into differ-
ent tubes: ethylenediaminetetraacetic acid (EDTA) tubes
for hematology and molecular testing, heparin for whole
blood assay and plain serum tubes for biochemistry and
serological testing. Once collected, samples were left at
4 °C overnight and then frozen at -80 °C until further
use.
All serum and whole blood extractions were per-
formed at the time of diagnosis between 2014 and 2016
and stored at -80 °C until use for this study.
Quantitative ELISA for the detection of L. infantum-
specific antibodies
The in-house ELISA was performed on sera of all dogs
studied as previously described [33]. All samples with an
optical density (OD) equal or higher to three were stud-
ied using a two-fold serial dilution ELISA as described
elsewhere [33].
Whole blood assay and sandwich ELISAs for the detection
of canine IFN-γ
Whole blood assay and sandwich ELISAs for the detec-
tion of canine IFN-γ were performed on blood of all
dogs studied as previously described [34].
IFAT for Rickettsia conorii, Ehrlichia canis, Anaplasma
phagocytophilum and Bartonella henselae antigens
Indirect immunofluorescence assays for the detection
of specific IgG antibody against R. conorii (Mega-
FLUO® RICKETTSIA conorii; Diagnostik Megacor, Hör-
branz, Austria), E. canis (MegaFLUO® EHRLICHIA canis;
Diagnostik Megacor. Hörbranz, Austria), A. phagocytophi-
lum (MegaFLUO® ANAPLASMA phagocytophilum; Diag-
nostik Megacor. Hörbranz, Austria) and B. henselae
(MegaFLUO® BARTONELLA henselae; Diagnostik Mega-
cor. Hörbranz, Austria) antigens were performed on sera.
IFATs were performed for 75 of the 77 dogs included in
this study: 61 dogs with clinical leishmaniosis and 14
apparently healthy dogs. The samples were diluted to 1:64
with PBS and 20 μl of every serum dilution was applied
per well. The slides were incubated for 30 min at 37 °C.
After that, a washing procedure was performed. The slides
were washed twice with PBS for 5 min and once with dis-
tilled water. After the washing procedure described, 15 μl
of FLUO FITC anti-dog IgG conjugate was added into
each well. The slides were incubated for another 30 min at
37 °C in the dark to protect the photosensitive conjugate.
The washing procedure described above was repeated.
After the second washing procedure, some drops of
mounting medium were added on the cover slips. The
slides were evaluated using a fluorescence microscope
(Leica DM6000 B; Leica Microsystems, Wetzlar,
Germany) at 200× and 400× magnification and each well
was compared to the fluorescence pattern seen in the
positive and negative controls. All samples were examined
by three different investigators to avoid errors of observa-
tion. All samples negative at 1:64 were considered negative
and no further dilutions were done.
All samples with a positive result were further investi-
gated using a two-fold serial dilution IFAT. The samples
were diluted to 1:128 and 1:256.
If a high positive result was observed, the samples
were diluted to 1:512 for R. conorii, and to both 1:512
and 1:1024 for E. canis, A. phagocytophilum and B. hen-
selae antigens. At this point, if the samples had not
reached a dilution with a negative result, the samples
were classified as a high positive for R. conorii (> 1:512)
or as a high positive for E. canis, A. phagocytophilum or
B. henselae antigens (> 1:1024).
Blood DNA extraction and PCR for the detection of
Ehrlichia, Anaplasma spp., Hepatozoon and Babesia spp.
and filaroid DNA
Blood DNA extraction was performed as previously de-
scribed [33, 35]. PCR was performed in samples from 76
of the 77 dogs included in the study: 60 with clinical
leishmaniosis and 16 apparently healthy dogs.
Ehrlichia and Anaplasma spp. DNA
Samples were screened in duplicates for the presence
of Ehrlichia/Anaplasma DNA using primers which
amplify a 123 bp of the 16S rRNA gene of the genera
Anaplasma and Ehrlichia by a qPCR assay as previ-
ously described [36]. Positive samples from this reac-
tion were further analysed in duplicates by
conventional PCR using primers EHR16SD and
EHR16SR which amplify a 345 bp fragment of the
16S rRNA gene of species of the genera Anaplasma
and Ehrlichia [37]. Positive and negative controls
were included in both PCRs.
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Hepatozoon and Babesia spp. DNA
Detection of Babesia spp. and Hepatozoon spp. DNA
was performed by a conventional PCR assay targeting a
400 bp fragment of the 18S rRNA gene by using the
following primers (3′-CCA GCA GCC GCG GTA ATT
C-5′) and (3′-CTT TCG CAG TAG TTY GTC TTT
AAC AAA TCT-5′) as described elsewhere [38]. All reac-
tions were run in a StepOne Plus thermocycler (Applied
Biosystems, Foster City, CA, USA). The samples were
screened in duplicates, and positive and negative controls
were included in each PCR run. Positive samples were
tested by additional PCRs using primers specifically de-
signed for the detection of a fragment of the 18S rRNA
gene of Babesia spp. (PIROA/PIROB) [39].
Filarioid DNA
A high resolution melt (HRM) real-time PCR was
performed as previously described [40] with some
modifications. The qPCR was performed to amplify a
partial sequence of the mitochondrial 12S gene of
filaroids of approximately 115 bp [41]. All reactions
were run in duplicates in a StepOne Plus thermocy-
cler (Applied Biosystems). Previously tested dog blood
samples positive and negative for both canine filaroids
were used as positive and negative controls,
respectively.
Sequencing PCR products
Samples that were positive by PCR were sequenced as
described elsewhere [42]. Only sequences with identity
between 97% and 100% and coverage above 99% were
considered as positive for an organism.
Statistical analysis
A descriptive study of the detection of antibodies, the
number of co-infections detected in each dog, accord-
ing to the results of the IFATs and PCRs performed,
and the proportion of the antibody levels for each
pathogen, was performed. The number of co-
infections was calculated by the sum of the positive
results for each test performed for each dog; there-
fore, the maximum number of co-infections was 7
(due to the fact that 4 IFATs and 3 PCRs were per-
formed) and every dog had a result between 0 (no
co-infections) and 7 (positive to all tests performed).
Quantitative variables were assessed using the Mann-
Whitney U-test and Spearman’s correlation. The
Mann-Whitney U-test was used to compare the me-
dians of quantitative variables of healthy and sick
dogs. Spearman’s correlation was used to test for as-
sociation between the number of co-infections de-
tected and the clinical data of sick dogs that
consisted of hematological and biochemical profile pa-
rameters, urinalysis with urinary protein creatinine
ratio, and serum electrophoresis, the antibody levels
in a quantitative ELISA for the detection of L. infan-
tum-specific antibodies, the result for Leishmania
qPCR and L. infantum IFN-γ concentration. Qualita-
tive variables of healthy and sick dogs were assessed
using Chi-quare, Fisher’s exact test, Kruskal-Wallis
test and multivariable logistic regression. Fisher’s
exact test was also used to compare the detection of
antibodies for the different pathogens with the clinical
signs observed in each sick dog. Kruskal-Wallis test
was used to compare the number of co-infections de-
tected with sex, age and season at time of diagnosis,
and the proportion of the level of antibodies detected
for each pathogen with clinical data of sick dogs.
Multivariable logistic regression was used to correlate
the detection of antibodies with the clinical data of
sick dogs; every factor was included in the analysis
and those that were less significant (P-value > 0.2)
were excluded until all factors presented a P-value
≤ 0.2. The remaining factors were further studied
using logistic regression. The Shapiro-Wilk test was
performed to detect the normality of the distribution
of the samples. A P-value < 0.05 was considered sta-
tistically significant. The statistical analysis was per-
formed using the R program i386 version 3.3.1 (R
Development Core Team) and the DeduceR program ver-
sion 1.7–16 (Deducer: A data Analysis GUI for R) for
Windows software.
Results
Signalment and clinical data
Both sexes were represented in the sick group with 37
males (61%) and 24 females (39%). Forty-two of 61 were
intact, 30 males and 12 females. The median age at diag-
nosis was 5 years with a range from 5 months to
13 years. Forty-one dogs were purebred (67%) and 20
were classified as mixed-bred (33%).
The 61 dogs were classified in different stages of leish-
maniosis after Solano-Gallego et al. [4]. Five (8%) were
classified as stage I with mild disease; 43 (70%) were
classified as stage II with moderate disease (31 classified
as substage IIa and 12 classified in substage IIb); 10
(16%) were classified as stage III with severe disease; and
3 (5%) were classified as stage IV with very severe
disease.
Both sexes were also represented in the healthy group
with 5 males (31%) and 6 females (38%). Gender was not
recorded in 5 dogs (31%). The median age at diagnosis
was 7 years with a range from 15 months to 13 years.
Seven dogs (44%) were purebred and 9 (56%) were clas-
sified as mixed-bred.
No statistical differences in age, sex or breed were
found between sick and apparently healthy dogs.
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IFAT
Comparison of dogs with canine leishmaniosis and
apparently healthy dogs
The results of IFAT for R. conorii, E. canis, A. phagocyto-
philum and B. henselae antigens in sick and healthy dogs
studied as well as PCR results are shown in Table 1. The
most frequent seropositive serology was for R. conorii
(52/75; 69%), followed by E. canis (43/75; 57%), A. pha-
gocytophilum (33/75; 44%) and B. henselae (28/75; 37%)
antigens. Of the total 75 assessed by IFAT, 11 (15%) ser-
oreacted with the 4 pathogen antigens, 16 (21%) with 3
pathogens, 24 (32%) with 2 of the pathogens screened
and 16 (21%) which seroreacted with 1 pathogen. Conse-
quently, 67 (89%) of the tested dogs seroreacted with at
least 1 antigen by IFAT. Sera from 8 (11%) of the tested
dogs did not react in any IFAT test performed. The pat-
tern of results of IFAT in dogs with clinical leishmaniosis
and healthy dogs is summarized in Table 2.
Fifty seven of the 61 (93%) dogs with clinical leishma-
niosis had a positive result to at least one of the IFAT
tests performed while 10 of the 14 (71%) dogs in the
healthy group also had a positive result. A significant dif-
ference was found when comparing the two groups of
dogs (Fisher’s exact test: P = 0.036, OR = 5.7, 95% CI =
1–35), thereby, dogs with clinical leishmaniosis were
more likely to be positive to at least one of the IFAT
compared to apparently healthy dogs. As shown in Table
1, the most frequent seropositivity in dogs with clinical
leishmaniosis was for R. conorii while E. canis antibodies
were the most frequent in the healthy group.
Dogs with clinical leishmaniosis were more likely to
have a positive result to more than one test (IFAT and
PCR) (Mann-Whitney test:, U = 243, Z = -2.6, n1 = 14, n2
= 61, P = 0.01) (Fig. 1), to be seroreactive to R. conorii
(Fisher’s exact test: P = 0.025, OR = 4.1, 95% CI = 1–17)
and to A. phagocytophilum (Fisher’s exact test: P = 0.002,
OR = 14.3, 95% CI = 2–626) antigens (Table 1) when
compared with healthy dogs. No difference was found
between seroreactivity to E. canis and B. henselae or be-
ing positive in the PCRs performed.
Of the 67 dogs that seroreacted to at least one patho-
gen, serial dilutions were performed, and the results are
listed in Table 3. Healthy dogs were more likely to have
a negative result or to have low antibody titers when
compared with sick dogs (Table 3). Healthy dogs were
likely to be negative for R. conorii (Fisher’s exact test: P
= 0.025, OR = 4.1, 95% CI = 1–17) and A. phagocytophi-
lum (Fisher’s exact test: P = 0.002, OR = 14.3, 95% CI =
2–626) antigens while a higher number of healthy dogs
were positive at the antibody titer of 1:64 for E. canis
when compared with sick dogs (Fisher’s exact test: P =
0.014, OR = 0.2, 95% CI = 0–0.9).
Furthermore, a significant association was found in all
dogs studied (healthy and sick dogs) between seroreac-
tivity to R. conorii and seroreactivity to E. canis (Fisher’s
exact test: P = 0.044, OR = 2.9, 95% CI = 1–9) or A. pha-
gocytophilum (Fisher’s exact test: P = 0.012, OR = 4.2,
95% CI = 1–16), and seroreactivity to A. phagocytophi-
lum and E. canis with high antibody titers (Chi-square
test: χ2 = 26.36, df = 6, P < 0.001).
Comparison of dogs with canine leishmaniosis depending
on co-infection status based on serological and molecular
tests
All statistically-significant associations found between
the pathogens tested and laboratory abnormalities and
clinical signs in sick dogs are summarized in Table 4.
Table 1 Results of IFAT for R. conorii, E. canis, A. phagocytophilum and B. henselae antigens and PCR for E. canis, Anaplasma spp.,
Hepatozoon spp., Babesia spp. and filarioids in dogs with clinical leishmaniosis and healthy dogs. A comparison of the groups was
made with Fisher’s exact test
Assays Number (%, 95% CI) of seroreactive dogs
IFAT Dogs with clinical leishmaniosis
(n = 61)
Healthy dogs
(n = 14)
Total dogs
(n = 75)
P-value
R. conorii 46 (75, 65–86) 6 (43, 17–69) 52 (69, 59–80) 0.025*
E. canis 34 (56, 43–68) 9 (64, 39–89) 43 (57, 46–69) 0.766
A. phagocytophilum 32 (53, 40–65) 1 (7, 0–21) 33 (44, 33–55) 0.002*
B. henselae 25 (40, 28–52) 3 (21, 0–43) 28 (37, 26–48) 0.147
PCR Dogs with clinical leishmaniosis
(n = 60)
Healthy dogs
(n = 16)
Total dogs
(n = 76)
P-value
Ehrlichia/Anaplasma spp. 8 (13, 5–22) 0 (0) 8 (11, 4–17)a 0.191
H. canis and Babesia spp. 1 (2, 0–5) 0 (0) 1 (1, 0–4)b 0.606
Filarioid DNA 0 (0) 0 (0) 0 (0) –
Abbreviations: CI confidence interval, IFAT immunofluorescence antibody test, PCR polymerase chain reaction
aTwo dogs remained with a positive result for Anaplasma platys after performing a conventional PCR and sequencing
bOne dog was detected with Hepatozoon canis infection. No Babesia spp. or filarioid DNA were detected
*P-values statistically significant
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When dogs with clinical leishmaniosis were compared
with the same sick group depending on each pathogen
specific seroreactivity (sick dogs seroreactive to one anti-
gen vs sick dogs seronegative to the same pathogen), no
statistical association was found between sex or the
blood parasite load of L. infantum and any of the patho-
gens tested by IFAT. The presence of R. conorii
antibodies was more frequent among sick dogs that were
older than 5 years-old at time of diagnosis (Logistic re-
gression: χ2 = 8.47, df = 1, P = 0.0036, OR = 1.03), sick
dogs with a lower albumin/globulin ratio than the aver-
age of the sick group (Logistic regression: χ2 = 5.27, df =
1, P = 0.0217, OR = 0.2) (Fig. 2), sick dogs with a lower
concentration of lymphocytes than the average of the
Table 2 Pattern of IFAT results in dogs with clinical leishmaniosis and healthy dogs for one or more antigens (R. conorii, E. canis, A.
phagocytophilum and B. henselae)
Antigens Number (%, 95% CI) of seroreactive dogs
Dogs with clinical leishmaniosis
(n = 57)
Healthy dogs
(n = 10)
Total dogs
(n = 67)
P-valuea
R. conorii alone 6 (11, 3–19) 0 (0) 6 (9, 2–16) 0.58
E. canis alone 5 (9, 1–16) 2 (20, 0–45) 7 (10, 3–18) 0.279
A. phagocytophilum alone 2 (4, 0–8) 0 (0) 2 (3, 0–7) 0.548
B. henselae alone 1 (2, 0–5) 0 (0) 1 (1, 0–4) 0.673
R. conorii and E. canis 6 (11, 3–19) 4 (40, 10–70) 10 (15, 6–24) 0.035*
R. conorii and A. phagocytophilum 3 (5, 0–11) 0 (0) 3 (4, 0–9) 0.458
R. conorii and B. henselae 5 (9, 1–16) 1 (10, 0–29) 6 (9, 2–16) 0.9
E. canis and A. phagocytophilum 0 (0) 0 (0) 0 (0) –
E. canis and B. henselae 0 2 (20, 0–45) 2 (3, 0–7) 0.02*
A. phagocytophilum and B. henselae 3 (5, 0–11) 0 (0) 3 (4, 0–9) 0.458
R. conorii, E. canis and A. phagocytophilum 10 (18, 8–27) 1 (10, 0–29) 11 (16, 8–25) 0.553
R. conorii, E. canis and B. henselae 2 (4, 0–8) 0 (0) 2 (3, 0–7) 0.548
R. conorii, A. phagocytophilum and B. henselae 3 (5, 0–11) 0 (0) 3 (4, 0–9) 0.458
E. canis, A. phagocytophilum and B. henselae 0 (0) 0 (0) 0 (0) –
R. conorii, E. canis, A. phagocytophilum and B. henselae 11 (19, 9–30) 0 (0) 11 (16, 8–25) 0.195
Abbreviations: CI confidence interval
aFisher’s exact test was performed
*P-values statistically significant
Fig. 1 Comparison of the number of co-infections detected by IFAT and PCR between dogs with clinical leishmaniosis and apparently healthy
dogs. A comparison of the means was performed with Mann-Whitney U-test (Mann-Whitney test: U = 243, Z = -2.6 n1 = 14, n2 = 61, P = 0.01)
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group (Logistic regression: χ2 = 4.66, df = 1, P = 0.0309,
OR = 0.9) and a high positive antibody level by the L.
infantum quantitative ELISA (Chi-square test: χ2 = 13.04,
df = 3, P = 0.005). The presence of E. canis antibodies
was only associated with sick neutered dogs (Chi-square
test: χ2 = 6.84, df = 1, P = 0.033) while the presence of A.
phagocytophilum antibodies was more frequent in sick
dogs with an increase of total protein (Logistic regres-
sion: χ2 = 4.64, df = 1, P = 0.0312, OR = 1.3), beta globu-
lins (Logistic regression: χ2 = 4.28, df = 1, P = 0.0385; OR
= 3.6) and gamma globulins (Logistic regression: χ2 =
5.37, df = 1, P = 0.0204, OR = 1.5) compared to the aver-
age of the tested sick group, a decrease of albumin (Lo-
gistic regression: χ2 = 9.82, df = 1, P = 0.0017, OR = 0.2),
lower albumin/globulin ratio (Logistic regression: χ2 =
12.77, df = 1, P = 0.0003, OR = 0) (Fig. 2) compared to
the average of sick group, a high positive antibody level
by the L. infantum quantitative ELISA (Chi-square: χ2 =
13.04, df = 3, P = 0.003) and dogs classified in stage III or
IV of the LeishVet clinical staging for L. infantum (Chi-
square: χ2 = 9.38, df = 4, P = 0.042) (Fig. 3) and being di-
agnosed in spring or winter (Chi square: χ2 = 10.59, df =
3, P = 0.014). The presence of B. henselae antibodies in
sick dogs was associated with an increase of total protein
(Logistic regression: χ2 = 11.67, df = 1, P = 0.0006, OR =
1.8), beta globulins (Logistic regression: χ2 = 10.44, df =
1, P = 0.0012, OR = 2.3) and gamma globulins (Logistic
regression: χ2 = 6.75, df = 1, P = 0.0094, OR = 1.5), a low
Table 3 IFAT antibody titers for R. conorii, E. canis, A. phagocytophilum and B. henselae antigens in dogs with clinical leishmaniosis
and healthy dogs. Fisher’s exact test was performed
Antibody
titers
Antigens Number (%, 95% CI) of seroreactive dogs
Dogs with clinical
leishmaniosis
(n = 61)
Healthy dogs
(n = 14)
< 64 R. conorii* 15 (25, 14–35) 8 (57, 31–83)
E. canis 27 (44, 32–57) 5 (36, 11–61)
A. phagocytophilum** 29 (48, 35–60) 13 (93, 79–100)
B. henselae 36 (59, 47–71) 11 (79, 57–100)
64 R. conorii 12 (20, 10–30) 2 (14, 0–33)
E. canis*** 17 (28, 17–39) 9 (64, 39–89)
A. phagocytophilum 17 (28, 17–39) 1 (7, 0–21)
B. henselae 6 (10, 2–17) 1 (7, 0–21)
128 R. conorii 0 (0) 0 (0)
E. canis 3 (5, 0–10) 0 (0)
A. phagocytophilum 4 (7, 0–13) 0 (0)
B. henselae 8 (13, 5–22) 1 (7, 0–21)
256 R. conorii 10 (16, 7–26) 0 (0)
E. canis 3 (5, 0–10) 0 (0)
A. phagocytophilum 3 (5, 0–10) 0 (0)
B. henselae 10 (16, 7–26) 1 (7, 0–21)
512 R. conorii 15 (26, 15–37) 4 (29, 5–52)
E. canis 2 (3, 0–8) 0 (0)
A. phagocytophilum 4 (7, 0–13) 0 (0)
B. henselae 0 (0) 0 (0)
> 512 R. conorii 9 (15, 6–24) 0 (0)
1024 E. canis 8 (13, 5–22) 0 (0)
A. phagocytophilum 3 (5, 0–10) 0 (0)
B. henselae 1 (2, 0–5) 0 (0)
> 1024 E. canis 1 (2, 0–5) 0 (0)
A. phagocytophilum 1 (2, 0–5) 0 (0)
B. henselae 0 (0) 0 (0)
Abbreviation: CI confidence interval
*P = 0.025, **P = 0.002, ***P = 0.014
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albumin/globulin ratio (Logistic regression: χ2 = 7.98, df
= 1, P = 0.0047, OR = 0.1), hematocrit (Logistic regres-
sion: χ2 = 7.1, df = 1, P = 0.0077, OR = 0.9) and
hemoglobin (Logistic regression: χ2 = 6.72, df = 1, P =
0.0095, OR = 0.8).
When dogs with clinical leishmaniosis were compared
with dogs from the same group that had different anti-
body titers (< 1:64, 1:64, 1:128, 1:256, 1:512; 1:1024 and
> 1:1024 for E. canis, A. phagocytophilum and B. hense-
lae and < 1:64, 1:64, 1:128, 1:256, 1:512 and > 1:512 for
R. conorii), no significant association was found between
sex, age, clinical signs and the clinical stage of leishma-
niosis. A comparison between the average of different
antibody titers was performed. The sick dogs that had a
high positive (> 1:512) antibody titer for R. conorii anti-
gen were positively associated with a decrease in albu-
min (Kruskal-Wallis H-test: χ2 = 12.98, df = 4, P =
0.0113), while a decrease of the albumin/globulin ratio
was associated with an increase of antibody titers for R.
conorii antigen (Kruskal-Wallis H-test: χ2 = 12.5, df = 4,
P = 0.014). Furthermore, sick dogs that had antibody ti-
ters for R. conorii antigen at 1:256 and 1:512 dilutions
were associated with production of IFN-γ after blood
stimulation with L. infantum antigen (Chi-square test:
χ2 = 10.74, df = 4, P = 0.028). These dogs with
leishmaniosis were also associated with being diagnosed
in the autumn (Chi-square test: χ2 = 11.44, df = 3, P =
0.011). No other pathogens were associated with the
production of IFN-γ after blood stimulation with L.
infantum antigen.
A significant association was found between a high E.
canis antibody titer (> 1:512) and a decrease in albumin
(Logistic regression: χ2 = 6.88, df = 1, P = 0.0087, OR =
0.2), albumin/globulin ratio (Logistic regression: χ2 =
7.24, df = 1, P = 0.0071, OR = 0), hematocrit (Logistic re-
gression: χ2 = 7.97, df = 1, P = 0.0048, OR = 0.7),
hemoglobin (Logistic regression: χ2 = 7.76, df = 1, P =
0.0053, OR = 0.6), RBC (Logistic regression: χ2 = 6.14, df
= 1, P = 0.0132, OR = 0.1) and an increase in gamma
globulins (Logistic regression: χ2 = 8.06, df = 1, P =
0.0045, OR = 2.4) and total protein (Logistic regression:
χ2 = 9.81, df = 1, P = 0.0017, OR = 3). Furthermore, a sig-
nificant association was found between high A. phagocy-
tophilum antibody titers (> 1:512) and a decrease in
albumin (Kruskal-Wallis H-test: χ2 = 21.68, df = 6, P =
0.0014) and the albumin/globulin ratio (Kruskal-Wallis
H-test: χ2 = 21.65, df = 6, P = 0.0014).
When dogs with clinical leishmaniosis were compared
with the same sick group according to the antibody ti-
ters, no statistical association was found between high B.
Table 4 Summary of signalment, clinical signs, laboratory abnormalities, and the results of diagnostic tests for leishmaniosis
significantly associated with seroreactivity to different antigens tested by IFAT and with positive results tested by PCR in dogs
with clinical leishmaniosis
Test
performed
Pathogen Laboratory abnormalitiesa, b Clinical signsc
IFAT R. conoriid Increase: ns
Decrease: albumin, albumin/globulin ratio, lymphocyte
concentration
ns
E. canise Increase: total protein, gamma globulins
Decrease: albumin, albumin/globulin ratio, hematocrit,
hemoglobin, RBC
ns
A. phagocytophilumf Increase: total protein, beta globulins, gamma globulins
Decrease: albumin, albumin/globulin ratio
No presence of lameness
B. henselae Increase: total protein, beta globulins, gamma globulins
Decrease: albumin/globulin ratio, hematocrit, hemoglobin
Marked lymphadenomegaly
PCR Ehrlichia/Anaplasma Increase: ns
Decrease: hematocrit, RBC, platelet concentration
ns
Hepatozoon/Babesia Increase: ns
Decrease: ns
ns
Co-infectionsg Increase: total protein, beta globulins, gamma globulins, UPC
Decrease: albumin, albumin/globulin ratio, lymphocyte
concentration, hematocrit, hemoglobin, MCH
ns
Abbreviations: ns non-significant, UPC urinary protein/creatinine ratio, MCH mean corpuscular hemoglobin
aAll statistically significant associations are present in the result section of this manuscript
bNo statistically significant association was found between the tested pathogens and other laboratorial abnormalities recorded (creatinine, urea, ALT, total
cholesterol, urinary protein/creatinine ratio, leucocyte, monocyte, neutrophil, eosinophil and reticulocyte concentrations)
cNo statistically significant association was found between the tested pathogens and the other clinical signs recorded (fever, weight loss, skin lesions, ocular
lesions, muscular atrophy, splenomegaly, vomiting and diarrhea, joint pain, polyuria and polydipsia, epistaxis and neurological disorders)
dStatistically significant association was also found with older age (> 5 year-old) and a high positive antibody level by L. infantum quantitative ELISA
eStatistically significant association was also found with neutering
fStatistically significant association was also found with a high positive antibody level by L. infantum quantitative ELISA, being in stage III or IV of LeishVet clinical
staging for L. infantum and being diagnosed in spring or winter
gStatistically significant association was also found with high parasite load of L. infantum and older age
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Fig. 2 The relationship of the albumin/globulin ratio with the results (positive or negative) of the different IFAT performed at a dilution of 1:64. A
comparison of the means was performed with logistic regression with the following results: R. conorii (χ2 = 5.27, P = 0.0217, OR = 0.2), E. canis (χ2 =
0.07, P = 0.7864, OR = 0.8), A. phagocytophilum (χ2 = 12.77, P = 0.0003, OR = 0) and B. henselae (χ2 = 7.98, P = 0.0047, OR = 0.1) antigens
Fig. 3 Results of IFAT for A. phagocytophilum antigen in dogs with clinical leishmaniosis based on the LeishVet clinical staging. Fisher’s exact tests
were performed; asterisks indicate P = 0.042
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henselae antibody titers and clinicopathological
abnormalities.
When dogs with clinical leishmaniosis were compared
with dogs from the same group that did not show the
same clinical signs, no statistically-significant association
was found between clinical signs and a positive result for
R. conorii and E. canis tested by IFAT. Lymphadenome-
galy was the only clinical sign significantly associated
with B. henselae tested by IFAT (Fisher’s exact test: P =
0.044, OR = 4, 95% CI = 1–19). In addition, B. henselae
seroreactivity was associated with marked lymphadeno-
megaly in sick dogs (Logistic regression: χ2 = 8.1, df = 1,
P = 0.0044, OR = 2.3). Interestingly, A. phagocytophilum
seroreactivity was associated with a lower probability of
suffering from lameness (Fisher’s exact test: P = 0.021,
OR = 0, 95% CI = 0–0.9) when compared with sick dogs
that did not seroreact with A. phagocytophilum antigen.
When dogs with clinical leishmaniosis were compared
with dogs from the same group divided according to the
number of co-infections (as detected by both IFAT and
PCR), no significant association was found between sex
or the clinical stage of leishmaniosis. A significant asso-
ciation between the number of co-infections and the
blood parasite load of L. infantum (r(66) = 0.3, P =
0.0252), age at time of diagnosis (r(67) = 0.2, P = 0.0496),
total protein (r(68) = 0.4, P = 0.0005), urinary protein/cre-
atinine ratio (UPC) (r(42) = 0.3, P = 0.0256), albumin
(r(66) = -0.4, P = 0.0008), albumin/globulin ratio (r(62)
= -0.5, P = 0.0001), beta globulins (r(56) = 0.4, P = 0.0025),
gamma globulins (r(56) = 0.4, P = 0.002), hematocrit (r(56)
= -0.3, P = 0.0446), hemoglobin (r(57) = -0.3, P = 0.045),
mean corpuscular haemoglobin (MCH) (r(48) = -0.4, P =
0.0074) and lymphocyte concentration (r(54) = -0.3, P =
0.0493) was found by Spearman’s correlation in sick
dogs.
PCR
Detection of Ehrlichia and Anaplasma spp. DNA
Of the 60 dogs with clinical leishmaniosis assessed, 8
(10.5%) were positive for Ehrlichia and Anaplasma by
real-time PCR. However, positive amplicons for E. canis
and Anaplasma qPCR did not produce a conclusive se-
quence. Of those 8 dogs, only 2 (2/8; 25%) maintained a
positive result after performing a conventional PCR. Se-
quencing showed that both dogs were detected with A.
platys (Table 5). All apparently clinically healthy dogs re-
sulted negative.
When comparing the results of the PCR between dogs
with clinical leishmaniosis and healthy dogs with Fisher’s
exact test, no difference was found between the groups.
When dogs with clinical leishmaniosis that were PCR
positive were compared to PCR negative sick dogs, a sta-
tistically significant association was found between a
PCR positive result and a decreased hematocrit (Logistic
regression: χ2 = 4.8, df = 1, P = 0.0281, OR = 0.9), RBC
(Logistic regression: χ2 = 3.9, df = 1, P = 0.048, OR = 0.4)
and platelet concentration (Logistic regression: χ2 = 3.98,
df = 1, P = 0.0461, OR = 0.9).
No significant association was found between the ori-
gin of the dogs (Barcelona or Tarragona) and a positive
result by PCR, although the two dogs that had a positive
result in the conventional PCR were from Tarragona.
Detection of Hepatozoon spp., Babesia spp. and filarioid
DNA
Of the 77 dogs assessed, only 1 (1.3%) had a positive re-
sult by PCR for Hepatozoon spp. This dog was diagnosed
with clinical leishmaniosis. After sequencing, the patho-
gen found was H. canis (Table 5). Babesia and filarioid
DNA were not detected in any of samples studied.
No statistically significant association was found be-
tween the positive H. canis PCR result and any of the
clinical characteristics of the sick dogs assessed.
Discussion
Previous studies have suggested that CanL could be af-
fected by other vector-borne pathogens. De Tommasi et
al. [26] found that infection with two or more vector-
borne pathogens could complicate the clinical presenta-
tion and severity of hematological abnormalities in dogs
with vector-borne disease. Mekuzas et al. [30] examined
naturally exposed dogs with L. infantum and E. canis co-
infection and proposed that the increase in clinical signs
in co-infection is associated with a synergistic patho-
logical effect between both pathogens. Furthermore, it
was suggested that E. canis infection could contribute to
the establishment of CanL [30]. In addition, Baneth et al.
[27] examined three dogs with E. canis and H. canis co-
infection in the same host cell and suggested that infec-
tion with one pathogen could permit or enhance inva-
sion of another. Conversely, Tabar et al. [43] examined
dogs with leishmaniosis and filariosis to detect filarial
spp., Wolbachia spp. and Leishmania co-infection, and
although an increase of disease severity and clinical signs
was observed with Leishmania-filarial co-infection, it
was also suggested that Wolbachia could have a protect-
ive role against Leishmania infection.
The present study demonstrated the presence of co-
infections with vector-borne pathogens in dogs with
clinical leishmaniosis living in the Mediterranean basin.
To the best of our knowledge, a statistically significant
relationship between sick dogs and a higher proportion
of co-infections with the detection of R. conorii or A.
phagocytophilum antibodies, when compared with
healthy dogs, was found for the first time. In agreement
with these results, a recent study documented that
co-infection with several tick-borne pathogens caused
clinical progressions of leishmaniosis in foxhounds in
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the USA [44]. In disagreement with previous reports
[26, 30, 45–47], no association was found between
seroreactivity to E. canis antigen and sick dogs with
leishmaniosis. Interestingly, a positive trend was noted
in our study in the association between seroreactivity
to B. henselae antigen and sick dogs when compared
with healthy dogs, although this was not statistically
significant. A previous study found a significant percent-
age of seroreactivity to Bartonella antigens in sick dogs
with clinical signs compatible with vector-borne diseases
when compared to clinically healthy dogs in the USA
where a large number of dogs were evaluated [48].
This study showed that more marked clinicopathologi-
cal abnormalities such as decrease in albumin or RBC
numbers or increase in globulins were noted in dogs
with clinical leishmaniosis with a higher number of co-
infections compared to dogs with CanL and a lower
number of co-infections. This is in agreement with pre-
vious studies [49–51]. Those studies demonstrated more
marked thrombocytopenia, an evident reduction of
platelet aggregation response, a significant increase in
activated partial thromboplastin time (APTT) and a re-
duction of the albumin/globulin ratio in dogs with clin-
ical leishmaniosis co-infected with E. canis [49–51].
Here, in the present study, we report for the first time
that certain clinicopathological abnormalities are more
marked in dogs with co-infections based on positive ser-
ology for R. conorii, A. phagocytophilum, E. canis and B.
henselae. It is important to highlight that based on the
present findings, moderate to marked hypoalbuminemia
or hyperglobulinemia in dogs with clinical leishmaniosis
should arouse the suspicion of co-infections with other
vector-borne pathogens. It has been shown that infec-
tion with tick-borne pathogens such as R. conorii, B.
henselae, A. platys, A. phagocytophilum and E. canis
may induce a decrease in serum concentration of nega-
tive acute phase proteins and an increase of positive
acute phase proteins [19, 52–55]. Albumin is a negative
acute phase protein whose level tends to decrease in in-
flammation or infection [56, 57].
Furthermore, it is noteworthy to mention that patho-
gen DNA was only detected in dogs with clinical leish-
maniosis although no significant difference in detection
was found when comparing with healthy dogs. Ana-
plasma platys and H. canis were confirmed as infecting
dogs with clinical leishmaniosis by PCR. Interestingly, a
significant association was found between dogs positive
for E. canis and Anaplasma spp. by PCR and a low
hematocrit, RBC and platelet concentration, which are
typical clinicopathological findings in canine ehrlichiosis
or anaplasmosis that could be worsened due to the co-
infection [16, 54, 58, 59].
In this study, clinical signs common in leishmaniosis
such as skin lesions, progressive weight loss, generalized
lymphadenomegaly or splenomegaly were also evaluated.
Lymphadenomegaly was the only clinical sign statisti-
cally associated with being seroreactive to B. henselae
antigen. Furthermore, seroreactivity to B. henselae anti-
gen was also positively associated with the degree of se-
verity of lymphadenomegaly classified as mild, moderate
or marked. Lymphadenomegaly is common in both dis-
eases, leishmaniosis and bartonellosis [2, 4, 21]. Interest-
ingly, an association was found between antibodies
against A. phagocytophilum and more advanced clinical
stages of leishmaniosis (LeishVet stage III and IV) in
agreement with a recent study [44]. Further studies are
needed to understand the relationship between co-
infections and clinical leishmaniosis in dogs.
Previous studies have evaluated the serological and
molecular evidence of exposure to vector-borne patho-
gens in dogs in Catalonia (Spain) [7, 8, 10, 12]. When
comparing our results to those of these studies, we
found a high increase of seropositivity rates to other
pathogens when studying dogs with clinical leishmanio-
sis. For example, the seroprevalence found for E canis in
our study was 56% in dogs with clinical leishmaniosis,
while those other studies found seroprevalences of 16.7%
[8] and 5% [12] for E. canis in healthy dogs. Interest-
ingly, the seroprevalence found for Bartonella spp. was
rather similar to that found in other studies carried out
in Catalonia and the Island of Mallorca. Roura et al. [7]
found a seroprevalence of 28% for B. vinsonii berkhoffii
while another study found a seroprevalence of 16.8% for
B. henselae and 1.1% for B. vinsonii berkhoffii [8].
Combining the serological and molecular results of the
present study with the findings from previous literature,
it is noteworthy to remark that co-infections patterns
are different in several geographical regions where the
dogs with leishmaniosis live and there is variability in
their life style, exposure to ticks and fleas, the species of
ectoparasites present in the area, and also on the pre-
ventative measures applied against ticks and fleas. For
example, in the present study, A. platys and H. canis
were only confirmed by PCR in dogs from the Tarragona
area. In the Mediterranean basin, where mosquitoes and
R. sanguineus (s.l.) ticks are common, it would be ex-
pected that the pathogens related to this tick species
would be also prevalent [15, 24, 60]. However, compar-
ing the present study with other recent studies from
Croatia [61], Greece [62, 63], Corsica [64], Cyprus [65],
Tunisia [66] and Israel [67], it is evident that E. canis,
Hepatozoon spp. Babesia spp. and Dirofilaria spp. are
circulating abundantly in those countries while, the re-
sults suggest that they are less common in Catalonia.
PCR is a technique that detects pathogen DNA and
can, therefore, confirm infection although a negative re-
sult does not completely exclude it. Serological tech-
niques, such as ELISA and IFAT, on the other hand,
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detect antibodies formed due to current infection or past
exposure to the pathogen studied. Quantitative serology
may be used to detect seroconversion, but seropositivity
may also result from cross-reaction with antibodies
formed against other organisms with similar antigens.
PCR also allows identification of the pathogen. Due to
the aforementioned characteristics, it is recommended
to use both techniques for diagnosis of some infectious
diseases [10, 68, 69]. In the present study, the results for
the different PCR performed had some important limita-
tions in the detection of positive samples, possibly due
to the low pathogen load in the blood. It is important to
note that with the particular pathogens studied, serial
evaluations of blood parasitaemia or bacteraemia by
PCR are recommended to enhance the likelihood of
PCR detection [70]. In the present study, no repeated
testing of the same dogs was performed and serology
was not used to detect seroconversion, although sero-
conversion could have been helpful in the detection of a
higher number of acute infections [19, 70]. Furthermore,
in the present study, no PCR was performed to detect
Rickettsia spp. such as R. conorii due to the low rickett-
siaemia usually found in dogs [10, 19, 71]. PCR to detect
Bartonella was also not performed. These bacteria are
often cultured with an enrichment medium for insect
cell culture growth (BAPGM) prior to PCR testing to in-
crease the likelihood of detecting this species [72].
The different cross-reactions that could have occurred
in this study should also be considered. It has been re-
ported that positive reaction found in serological tests
for R. conorii in dogs might be due to infection with
other spotted fever group (SFG) Rickettsia spp. such as
R. massiliae, R. slovaca or R. aeschlimannii, which are
common in ticks in the Mediterranean basin countries
[19, 73, 74]. Furthermore, serological cross-reactivity be-
tween A. phagocytophilum and A. platys is common, due
to their antigenic similarity [12, 75, 76]. In Europe, A.
phagocytophilum is usually transmitted by I. ricinus ticks
while A. platys is suspected to be transmitted by R. san-
guineus (s.l.) [15–17]. Taking into account that the main
tick that inhabits the Barcelona area is R. sanguineus
(s.l.) [77], it can be suggested that the positive serological
reactivity was probably aimed at A. platys and not A.
phagocytophilum. Similarly, E. canis can also have some
degree of cross-reactivity with Anaplasma spp. [78, 79].
In the present study, 22 dogs seroreacted to both, E.
canis and A. phagocytophilum, without positive PCR and
sequencing. It could be suggested that these dogs were
exposed only to one of the two vector-borne pathogens
detected and they could have been infected by A. platys,
the only Anaplasmataceae species detected by PCR. In
addition, other species of Bartonella apart from B. hen-
seale such as Bartonella vinsonii berkhoffii are associated
with clinical illness in dogs. Therefore, the present study
might have detected Bartonella seroreactivity related to
infection with these other Bartonella species [80].
Another finding of the present study was the detection
of a higher number of pathogens by IFAT and PCR in
older dogs compared to young dogs. It is reasonable that
older dogs would have more time and opportunity to be
exposed to the different pathogens studied, although
young dogs could be more susceptible to infections due
to the immaturity of the immune system [81–84]. In
agreement, Amusategui et al. [9] found that R. conorii
infection was significantly associated with older age.
However, a recent study [85] found that young animals
are more susceptible to co-infection of Leishmania and
Babesia spp. and Miró et al. [12] found that dogs under
one year of age showed higher seropositivity rates for E.
canis and Borrelia burgdorferi compared to dogs older
than one year. Further studies are needed to understand
the relationships between age and different vector-borne
diseases, taking into account other factors such as life-
style and location.
When studying vector-borne pathogens, it is also ex-
pected to find a relationship between the time of infec-
tion detection and the season when the vector is more
active. In this study, only the results of IFAT for A. pha-
gocytophilum antigen showed an association between
seropositivity and season, in this case spring or winter.
The vector for A. phagocytophilum present in Spain is
the I. ricinus tick [15–17], which has the highest activity
between April and June, a decrease of activity thereafter
and a slight increase in the autumn-winter months [86].
When evaluating our results, it could be suggested that
dogs with a positive IFAT for A. phagocytophilum were
infested with these ticks and a subsequent infection oc-
curred. However, I. ricinus is usually not found in the
Mediterranean area [15, 76, 77, 86] and it parasites dogs
only in rare cases since its natural hosts are wild animals
such as rodents, wild boars and wild ruminants [15, 77].
Consequently, antibodies reactive with A. phagocytophi-
lum are likely to have been formed against A. platys, for
which the tick R. sanguineus (s.l) is suspected as its main
vector. Different studies [76, 87, 88] have evaluated
the seasonal dynamics of this tick in the Mediterra-
nean basin and, although it has been stated that the
highest activity of R. sanguineus (s.l.) is in summer,
this tick can infest dogs during all seasons [76, 87].
Furthermore, A. platys is known to cause subclinical
infections [16, 55, 89] and in fact the detection of this
infection might not be associated with a certain sea-
son. On the other hand, no association was found be-
tween other vector-borne pathogens and seasonality.
This could be due to the high probability of subclin-
ical or chronic infection with E. canis [16] with the
consequent delay in detection of infection as well as
with leishmaniosis [2, 4, 6].
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Conclusions
This study demonstrates that dogs with clinical leishma-
niosis from the Barcelona and Tarragona areas have a
higher rate of co-infections with other vector-borne
pathogens when compared with healthy controls. Fur-
thermore, individual seroreactivity to R. conorii, E. canis,
A. phagocytophilum and B. henselae antigens was associ-
ated with more pronounced clinicopathological abnor-
malities when compared with sick dogs that were
seronegative to the same individual antigen. Interest-
ingly, only seroreactivity of leishmaniotic dogs to A. pha-
gocytophilum was associated with increased disease
severity of clinical leishmaniosis.
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